
Endologix
Developer and manufacturer of minimally invasive treatments for aortic disorders.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
$170m | Post IPO Debt | ||
Total Funding | 000k |
USD | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | (13 %) | (9 %) | (21 %) | 27 % | 6 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | (10 %) | (27 %) | (17 %) | (37 %) | (15 %) | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (36 %) | (50 %) | (45 %) | (83 %) | (48 %) | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Endologix is a medical device company specializing in innovative vascular therapies aimed at improving patient outcomes. The company focuses on developing groundbreaking solutions for the treatment of abdominal aortic aneurysms (AAA) and peripheral artery disease (PAD). Endologix serves healthcare professionals and patients by providing advanced medical devices that offer durable and personalized repair options. The company's flagship products include the AFX, Ovation, and ALTO systems, which are designed to preserve native bifurcation and ensure reliable, stable repairs. Endologix operates in the medical devices market and generates revenue through the sale of its specialized vascular therapy products. The business model revolves around continuous innovation and clinical excellence to meet the critical unmet needs in vascular care.
Keywords: vascular therapies, medical devices, AAA treatment, PAD solutions, healthcare professionals, patient outcomes, durable repair, personalized care, clinical excellence, innovation.
Tech stack
Investments by Endologix
Edit

